Exosens Shares Drop 2.5% Breaking New Support Despite EIB Loan
The French specialist in night vision and imaging technologies for defense continues its downturn in mid-afternoon trading. The stock breaks a new technical threshold and ranks at the bottom of the SBF 120, while the broader index trends upward. The movement occurs a day after securing European funding.
A New Support Level Broken as SBF 120 Advances
Exosens shares fall 2.81% to €53.60 during the session, while the SBF 120 gains 0.69% at the same time. The stock is at the tail end of the SBF 120. The session saw the breach of the support level at €55.15, which was the previous day's closing price. The decline is part of a turbulent sequence: the stock has lost nearly 12% over the week and 17% over the month, following a 4.4% drop recorded the previous day.
The annual performance remains positive, over 27%. The technical setup has significantly deteriorated. The price is now 12.8% below its 20-day moving average at €61.49 and 14% below its 50-day moving average at €62.33, while the 200-day moving average at €54.69 barely stays above the current price. The RSI at 32 indicates seller fatigue after several sessions of decline, without yet entering a clear oversold zone.
EIB Financing Fails to Support the Stock Despite Industrial Stakes
The company announced on Thursday that it had secured a €140 million credit facility from the European Investment Bank, backed by the InvestEU program. The financing is intended to support research, development, and industrial investments in the European defense, surveillance, and civilian sectors. The day before, the company had unveiled PhaseStudio, an optical wavefront measurement software developed over four years.
These two consecutive announcements have not stopped the selling pressure on the stock. The decline occurs in a context of easing in the Paris defense sector, as oil flows through the Strait of Hormuz resume and the geopolitical risk premium decreases. The next technical area to watch remains the 200-day moving average at €54.69, immediately above the current price, which has not yet been breached at close.
